Severe Pain Profiles and Associated Sociodemographic and Clinical Characteristics in Individuals With Sickle Cell Disease

Mitchell R. Knisely(Duke University), Nirmish Shah(Duke University), Qing Yang(Guangzhou University of Chinese Medicine), Rita Masese(Duke University), Paula Tanabe(Duke University), Meilin Jiang(Duke University)

Clinical Journal of Pain

July 9, 2021

10.1097/ajp.0000000000000957

Cited by 8

Related Papers

Management of Sickle Cell Disease

|JAMA|2014|1.6k

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

|JAMA|2021|821

Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus

|Immunity|2016|378

Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members

|Survey of Anesthesiology|2015|270

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

|Clinical Cancer Research|2018|218